2025 Florida Society of Clinical Oncology (FLASCO) Fall Oncology Congress
In-Person Event
Oct 23 - 25, 2025
Orlando, Florida, USA
4.75 AMA PRA Category 1 Credits™ ...OVERVIEW
2025 Florida Society of Clinical Oncology (FLASCO) Fall Oncology Congress is organized by Florida Society of Clinical Oncology (FLASCO) and will be held from Oct 23 - 25, 2025 at Signia by Hilton, Orlando Bonnet Creek, Orlando, Florida, United States of America.
Description:
The Florida Society of Clinical Oncology is pleased to announce the 2025 Fall Congress, a premier two-day event designed to elevate the practice of oncology through evidence-based education and clinical collaboration. This comprehensive conference will feature five specialized educational tracks: Multidisciplinary, Pharmacy, Advanced Practice Providers (APP), Nurse/Navigator, and Administrator, providing a platform for professionals across all oncology disciplines to engage in the latest scientific advancements and clinical practices.
The congress will focus on the most current trends in oncology care, integrating cutting-edge research with practical applications aimed at improving patient outcomes. Attendees will have the opportunity to participate in presentations from renowned experts, offering insights into innovative therapies, multidisciplinary approaches, and emerging treatment paradigms. These sessions will foster dynamic discussions on optimizing clinical workflows, enhancing patient care strategies, and addressing complex challenges in oncology.
Continuing education credits will be provided for all participants, ensuring the advancement of professional competencies in the evolving field of oncology. Additionally, FLASCO members can attend the congress at no cost with an active membership, granting exclusive access to this essential gathering of leaders in oncology.
Learning Objectives:
- Participants should be able to apply the knowledge gained at this conference to enhance their skills, performance, and ultimately improve patient outcomes in their daily practice.
- Apply the novel therapy for different types of solid and hematological malignancies recently adopted by the regulatory entities.
- Discuss the most common adverse events of novel therapies entering the treatment algorithm.
- Identify opportunities for therapeutic intervention using a multi-disciplinary team approach to care.
- Identify & understand barriers to care including cost barriers and access barriers
KEY DATES
23 Oct, 2025
Event Start Date
25 Oct, 2025
Event End Date
ACCREDITATION & CREDITS
Joint Accreditation and Credit Designation Statements
In support of improving patient care, this activity has been planned and implemented by i3 Health and the Florida Society of Clinical Oncology (FLASCO). i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
i3 Health designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.
Physician Assistants/Associates
i3 Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.75 AAPA Category 1 CME credits. Approval is valid until 10/25/2025. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Nursing Continuing Professional Development
A maximum of 4.75 ANCC contact hours may be earned by learners who successfully complete this nursing continuing professional development activity.
Continuing Pharmacy Education
i3 Health has approved this knowledge-based activity for 4.75 ACPE CE hours. The Universal Activity Number for this activity is JA0008128-0000-25-028-L01-P. Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity and the evaluation by providing your NABP ID and DOB, which must be submitted within 60 days of completion.
Social Workers
As a Jointly Accredited Organization, i3 Health is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 4.75 general continuing education credits.
TARGET AUDIENCE
PhysicianNursingPharmacistPhysician AssistantCliniciansOncologistsNursesSocial WorkersNurse PractitionersAdministratorsAdvanced Practice ProvidersSPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
Signia by Hilton, Orlando Bonnet CreekRELATED CONFERENCES & LIVE WEBINARS
Quick Links